GLP-1 Strategy Tool — Model GLP-1 Coverage Strategies
GLP-1 Strategy Tool
Model and compare GLP-1 medication coverage strategies across cost, clinical outcomes, and employee access.
1
Employer Profile2
ObjectivesStep 1 of 2Employer Profile
Step 1
Employer Profile
Enrollment and current GLP-1 coverage
% of enrolled with T2D or obesity diagnosis. Industry avg: 12–18%
GLP-1 medications (Ozempic, Wegovy, Mounjaro, Zepbound) represent the fastest-growing pharmacy cost category for employers. This tool models 5 coverage strategies with cost and clinical outcome projections.